Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
==================================================================================================================================

* Benny Johnson
* Cara L Haymaker
* Edwin R Parra
* Luisa Maren Solis Soto
* Xuemei Wang
* Jane V Thomas
* Arvind Dasari
* Van K Morris
* Kanwal Raghav
* Eduardo Vilar
* Bryan K Kee
* Cathy Eng
* Christine M Parseghian
* Robert A Wolff
* Younghee Lee
* Daniele Lorenzini
* Caddie Laberiano-Fernandez
* Anuj Verma
* Wenhua Lang
* Ignacio I Wistuba
* Andrew Futreal
* Scott Kopetz
* Michael J Overman